Posts Tagged ‘therapy’
Why cognitive behavioral therapy (CBT) should be first-line treatment for chronic insomnia
. Cognitive behavioral therapy offers a drug-free method for managing insomnia (Harvard Health): “Many people with insomnia turn to sleeping pills, which often have unwanted side effects. Few of them know about an equally effective therapy that targets the root cause of insomnia without medications. Called
Read MoreWill consumer-led transcranial direct current stimulation revolutionize or hurt mental health?
. Therapy Borne on Electrical Currents (The New York Times): “…This is Thync, the latest in transcranial direct current stimulation, or tDCS. The manufacturer says the device, to come out later this year, can alter the user’s mood in minutes via electric current
Read MoreTherapy or antidepressants? Coming soon: Brain activity “fingerprints” to personalize depression treatments
. To Treat Depression, Drugs or Therapy? (The New York Times): “Until recently, many experts thought that your clinician could literally pick any antidepressant or type of psychotherapy at random because, with a few clinical exceptions, there was little evidence to favor one treatment over another for a given patient
Read MoreUpdate: Let’s transform brain health from “suffer-in-silence” to “let-me-take-control”
Time for our September 2014 e‑newsletter, featuring a wealth of insights and innovations reports…including four thought-provoking interviews with Sponsors of the 2014 SharpBrains Virtual Summit (October 28–30th). Enjoy! New perspectives at the frontier of Brain, Health & Innovation: Barbara Arrowsmith Young: Every kid should practice stress reduction and targeted cognitive exercises at school Michael Meagher (Cogniciti): Let’s transform brain…
Read MoreThree Ways to Bring Mindfulness Into Therapy
— Many therapists have come to regard cultivating moment-to-moment awareness as a curative mechanism that transcends diagnosis, addresses underlying causes of suffering, and serves as an active ingredient in most effective psychotherapies. The clinical value of
Read MoreRethinking Alzheimer’s research, beyond amyloid deposition, via new funding models
How a new approach to funding Alzheimer’s research could pay off (MIT News): “More than 5 million Americans suffer from Alzheimer’s disease, the affliction that erodes memory and other mental capacities, but no drugs targeting the disease have been approved by the U.S. Food and Drug Administration since 2003…Lo and three co-authors propose
Read More